Marshall & Sullivan’s Verastem VSTM Stock Holding History

Marshall & Sullivan’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-42	Closed	-$3K	–	63
2016 Q1	$3K	Hold	42	–	–	﹤0.01%	60
2015 Q4	$3K	Hold	42	–	–	﹤0.01%	61
2015 Q3	$2K	Buy	+42	New	+$3.32K	﹤0.01%	64

Other funds holding VSTM

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Marshall & Sullivan's VSTM Position: Q2 2016 in Review

Marshall & Sullivan sold out of Verastem (VSTM) in Q2 2016, closing a stake of 42 shares — an estimated $3K sold.

Marshall & Sullivan first reported a position in VSTM in Q3 2015 and held it in 3 quarters. The position peaked at $3K in Q1 2016. 67 funds tracked by Wall St. Rank hold VSTM as of Q2 2016.

Marshall & Sullivan reported no remaining Verastem position as of Q2 2016 after selling out during the quarter.
Marshall & Sullivan sold 42 Verastem shares in Q2 2016, an estimated $3K.
Marshall & Sullivan first reported a position in Verastem in Q3 2015 and held it in 3 quarters.
Marshall & Sullivan's Verastem position peaked at $3K in Q1 2016.
67 funds tracked by Wall St. Rank held Verastem as of Q2 2016.

Based on Marshall & Sullivan's 13F filing for Q2 2016, filed 12 Aug 2016.